ANCILIA BIOSCIENCES
Ancilia Biosciences develops engineered bacterial therapies to treat diseases linked to the microbiome. It provides and develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications.
ANCILIA BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.anciliabio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Ancilia Biosciences
Bioverge
Bioverge investment in Seed Round - Ancilia Biosciences
Harmonix Fund
Harmonix Fund investment in Seed Round - Ancilia Biosciences
Official Site Inspections
http://www.anciliabio.com Semrush global rank: 8.27 M Semrush visits lastest month: 588
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Ancilia Biosciences"
Home | Ancilia Bio
Platform. CoVE™ Computational Virome Engine Our CoVE™ platform tackles the uncharted territory of the virome by addressing the challenges of virome identification and characterization. The CoVE™ platform has the dual ability to …See details»
Ancilia Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Ancilia Biosciences develops engineered bacterial therapies to treat diseases linked to the microbiome. It provides and develops novel bacterial therapies …See details»
Team - anciliabio.com
Rodolphe is the T. R. Klaenhammer Distinguished Professor at North Carolina State University. Prior to joining NC State, he was global R&D director at Danisco and Dupont, where he and …See details»
Ancilia Bio Company Profile 2024: Valuation, Funding ... - PitchBook
Ancilia Bio General Information Description. Developer of virus-resistant live bacterial products designed to modulate the human microbiome. The company targets the viral components of …See details»
Ancilia Biosciences Announces Closing of $4.2 Million Financing
The company is headquartered in New York City and its founders and advisors include scientific leaders across CRISPR and the virome. For more information, visit anciliabio.com. Contacts: …See details»
Ancilia Biosciences - LinkedIn
Ancilia is incredibly proud and honored to be named 1 of just 23 winners from over 1,700 proposals submitted to ARPA-H's Sprint for Women's Health program announced today by the White House and ...See details»
Ancilia Bio Summary - Craft
See insights on Ancilia Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Ancilia Bio - Products, Competitors, Financials, Employees ...
Ancilia Biosciences Selected to Receive $3 Million Award from ARPA-H’s Sprint for Women’s Health. Oct 23, 2024. Ancilia Biosciences —Award from Highly Competitive Initiative Will …See details»
Ancilia Biosciences | VentureRadar
Website: https://www.anciliabio.com/ Develops bacterial therapies and products with immunity against viruses using CRISPR technology. VentureRadar Research / Company ...See details»
Ancilia Biosciences Announces Closing of $4.2 Million Financing
Jul 17, 2024 Supports Development of Ancilia’s Unique Platform that Harnesses CRISPR’s Natural Function to Increase the Utility of Live Bacterial Products for Therapeutic and Other …See details»
Microbial Post — Ancilia Biosciences Secures $4.2 …
In a recent move that underscores its innovative approach to biotechnology, New York-based Ancilia Biosciences has successfully closed a $4.2 million financing round.See details»
Ancilia Presentation and Q&A with CEO Alexandra Sakatos
May 7, 2021 Ancilia is a computational bio-platform company that engineers phage-resistant bacterial therapeutics utilizing CRISPR/Cas to treat microbiome-linked diseases including …See details»
Ancilia Biosciences Announces Closing of $4.2 Million
Jul 17, 2024 For more information, visit anciliabio.com. Contacts: Ancilia Corporate: Alexandra Sakatos, PhD Chief Executive Officer [email protected]. Ancilia Media: Barbara Lindheim …See details»
Ancilia Biosciences Awarded NSF Grant to Advance Platform …
Aug 3, 2021 Ancilia Biosciences (www.anciliabio.com) is developing virus-resistant live bacterial biotherapeutics (LBPs) to alter the gut microbiome and treat disease. Ancilia was founded to …See details»
Ancilia Biosciences | Deep Science Ventures Job Board
Anciliabio.com. Locations. New York, NY, USA. industry. Biotechnology · DeepTech · Health. Size. 11-50 employees. Stage. Other. founded in. 2019. Ancilia Biosciences develops …See details»
Contact - anciliabio.com
[email protected]. Address 3960 Broadway, 6th Floor Alexandria Launchlabs New York, NY 10032 Get directions. CRISPR-mediated viral immunity Designed by nature, harnessed by …See details»
Ancilia Biosciences - VentureRadar
Similar Companies: Lous Biosciences USA Privately Held Locus Biosciences has developed a platform to design and deliver custom CRISPR-Cas systems directly to specific bacteria. …See details»
Ancilia Biosciences Selected to Receive $3 Million Award From …
Ancilia has obtained both issued and pending patents for its technologies. The company is headquartered in New York City. For more information, visit anciliabio.com. Contacts: Ancilia …See details»
Ancilia Biosciences Selected to Receive $3 Million Award from …
Oct 23, 2024 —Award from Highly Competitive Initiative Will Enable Ancilia to Advance Its Lead Program through IND Filing for Its First Clinical Trial—See details»
News | Designed by Nature, harnessed by Ancilia - anciliabio.com
Latest news from Ancilia Bio. Press Release. Ancilia Biosciences Selected to Receive $3 Million Award From ARPA-H's Sprint for Woman HealthSee details»